N

National Taiwan University Hospital | Cardiovascular Clinical Trial Research Center

Research site
(Unclaimed)
Location
Zhongshan South Road, Zhongzheng District Room 001, 5F.-05, No. 7-Central Wing, Taipei, Taipei, Taiwan
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid [mRNA]-...

Enrolling
Melanoma
Biological: Pembrolizumab
Biological: V940

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to...

Enrolling
Carcinoma, Renal Cell
Drug: Belzutifan
Biological: Pembrolizumab

This is a study evaluating the safety and efficacy of bomedemstat (MK-3543) compared with the best available treatment (BAT) in participants with ess...

Enrolling
Essential Thrombocythemia
Drug: Bomedemstat
Drug: Anagrelide

This is a phase I/II multicenter, open-label umbrella platform study that will evaluate the safety and efficacy of investigational agents with pembro...

Enrolling
Esophageal Squamous Cell Carcinoma (ESCC)
Biological: MK-4830
Biological: Pembrolizumab

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary...

Enrolling
Hypercholesterolemia
Familial Hypercholesterolemia
Drug: MK-0616
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of nemtabrutinib compared to investigator's choice of fludarabine plus cyclophospham...

Enrolling
Small Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Biological: Truxima
Drug: Cyclophosphamide

This is a Phase 1/2, multicenter, randomized, open-label umbrella platform study to evaluate the safety and efficacy of investigational agents with o...

Enrolling
Esophageal Squamous Cell Carcinoma
Drug: Acetaminophen (or equivalent)
Drug: Dexamethasone (or equivalent)

This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experien...

Enrolling
RSV Infection
Biological: Placebo
Biological: Clesrovimab

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of MK-0616, an oral proprotein convertase subtilisin/kexin type 9...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Placebo
Drug: MK-0616

The purpose of this study is to evaluate pathological complete response (pCR) rate of coformulated favezelimab/pembrolizumab (MK-4280A) or pembrolizu...

Enrolling
Endometrial Cancer
Solid Tumor
Drug: lenvatinib
Biological: pembrolizumab

Trial conditions

Esophageal Cancer (2 trials)
Esophageal Squamous Cell... (2 trials)
Hypercholesterolemia (2 trials)
Arteriosclerosis (1 trial)
B-Cell Chronic Lymphocyt... (1 trial)
Carcinoma (1 trial)
Endometrial Cancer (1 trial)
Essential Thrombocythemia (1 trial)
Hyperlipoproteinemia Typ... (1 trial)
Leukemia (1 trial)

And 6 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems